These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26934062)

  • 21. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics.
    Kwon JS; Kim SN; Han J; Lee SI; Chang JS; Choi JS; Lee HJ; Cho SJ; Jun TY; Lee SH; Han C; Lee KU; Lee KK; Lee E
    Int Clin Psychopharmacol; 2015 Nov; 30(6):320-8. PubMed ID: 26196188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-month paliperidone palmitate - a new treatment option for schizophrenia.
    Bernardo M; Bioque M
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):899-904. PubMed ID: 27206330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.
    Citrome L
    Expert Rev Neurother; 2017 Oct; 17(10):1029-1043. PubMed ID: 28832262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong.
    Choon JWY; Wu DBC; Chong HY; Lo WTL; Chong CSY; Chung WS; Chui EMC; Tomlinson B; Lee VWY; Lee SC; Lee KKC
    J Med Econ; 2019 Mar; 22(3):273-279. PubMed ID: 30561238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.
    Bossie CA; Turkoz I; Alphs L; Mahalchick L; Fu DJ
    J Nerv Ment Dis; 2017 Apr; 205(4):324-328. PubMed ID: 28005578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.
    Greenberg WM; Citrome L
    Neurol Ther; 2015 Dec; 4(2):81-91. PubMed ID: 26662360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preclinical discovery and development of paliperidone for the treatment of schizophrenia.
    Wesołowska A; Jastrzębska-Więsek M; Cios A; Partyka A
    Expert Opin Drug Discov; 2020 Mar; 15(3):279-292. PubMed ID: 31661992
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder].
    Bellantuono C; Santone G
    Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode.
    Berwaerts J; Melkote R; Nuamah I; Lim P
    J Affect Disord; 2012 May; 138(3):247-58. PubMed ID: 22377512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paliperidone Palmitate Depot in the Long-term Treatment of Psychotic Bipolar Disorder: A Case Series.
    Buoli M; Ciappolino V; Altamura AC
    Clin Neuropharmacol; 2015; 38(5):209-11. PubMed ID: 26366967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.
    Turkoz I; Fu DJ; Bossie CA; Sheehan JJ; Alphs L
    J Affect Disord; 2013 Aug; 150(1):17-22. PubMed ID: 23517884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance.
    Mauri MC; Reggiori A; Minutillo A; Franco G; Pace CD; Paletta S; Cattaneo D
    Pharmacopsychiatry; 2020 Sep; 53(5):209-219. PubMed ID: 32155657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early predictors of a clinical response at 8 weeks in patients with first-episode psychosis treated with paliperidone ER.
    Chung YC; Cui Y; Kim MG; Kim YJ; Lee KH; Chae SW
    J Psychopharmacol; 2016 Aug; 30(8):810-8. PubMed ID: 27334812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study.
    Berwaerts J; Xu H; Nuamah I; Lim P; Hough D
    J Affect Disord; 2012 Jan; 136(1-2):e51-e60. PubMed ID: 20624657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paliperidone Palmitate Intramuscular 3-Monthly Formulation: A Review in Schizophrenia.
    Lamb YN; Keating GM
    Drugs; 2016 Oct; 76(16):1559-1566. PubMed ID: 27699643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paliperidone palmitate in short- and long-term treatment of schizophrenia.
    Valsecchi P; Barlati S; Garozzo A; Deste G; Nibbio G; Turrina C; Sacchetti E; Vita A
    Riv Psichiatr; 2019; 54(6):235-248. PubMed ID: 31909750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone.
    Schoretsanitis G; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1237-1253. PubMed ID: 30449206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics.
    Hargarter L; Cherubin P; Bergmans P; Keim S; Rancans E; Bez Y; Parellada E; Carpiniello B; Vidailhet P; Schreiner A
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():1-7. PubMed ID: 25448776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.